Reading Time: 5 minutesWhile we work hard for a cure, it is essential we support those living with MND now. Professor Chris McDermott, Professor of Translational Neurology at
Search Results for: project mine
Reading Time: 6 minutesPlease note that this blog talks about sensitive topics such as death and tissue donation throughout. Researchers use many different tools to increase our understanding
Reading Time: 5 minutesDespite extensive research, the causes of MND remain largely unknown. Recent investigations have begun to shed light on the gut microbiome and whether it may
Reading Time: 7 minutesWeight loss is a problem for many people living with MND, with approximately 20% of people already having lost 10% of their weight at diagnosis.
Reading Time: 7 minutesEach year we host the International Symposium on ALS/MND in December and this is the largest medical and scientific conference specific to MND. The 34th
Reading Time: 5 minutesMy current work focuses on looking at the cell types that are affected in MND and how they impact each other. Motor neurons, the main cell type affected in MND, connect our brains and muscles. This connection is what allows us to move. In MND, these cells start to die, which is what leads to progressive paralysis. But motor neurons aren’t the only cell types affected by MND. They are surrounded by many more cells called glia, which have roles in keeping our motor neurons healthy.
Reading Time: 6 minutesOn the 8 September 2023, members of the Research Development team at the MND Association attended the 4th UCL Queen Square Motor Neuron Disease Centre
Causes and disease mechanisms Genetic Research Markers of Disease Progression MND Research Models of MND Research we fund Treatments Unproven treatments
A stepping stone to becoming future leaders in MND research
Reading Time: 6 minutesMND is a very complex disease and collaboration within the research community is key to building on our current understanding of the disease biology and
Reading Time: 6 minutesQurAlis, a biotechnology company focused on developing precision medicines for MND and other neurodegenerative diseases, has announced the opening of a clinical trial in the